A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children

Completed · Phase 3

Conditions studied: Pulmonary Arterial Hypertension

In brief

Active treatment, dose-blinded extension study evaluating the safety and long term efficacy of sildenafil citrate in children with PAH.

Key facts

Study ID

NCT00159874

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

234

Starts

2004-01-01

Expected to finish

2012-12-01

Last updated by the study team

2021-02-01

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must complete the 16 Week double-blind efficacy study A1481131.

You may not qualify if…

• Any patient who did not complete Study A1481131.

Where it is running

• Pfizer Investigational Site — Palo Alto, California, United States
• Pfizer Investigational Site — Palo Alto, California, United States
• Pfizer Investigational Site — Stanford, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Columbus, Ohio, United States
• Pfizer Investigational Site — Charleston, South Carolina, United States
• Pfizer Investigational Site — Seattle, Washington, United States
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — Puente Alto, Santiago Metropolitan, Chile
• Pfizer Investigational Site — Medellín, Antioquia, Colombia
• Pfizer Investigational Site — Bogota, Cundinamarca, Colombia
• Pfizer Investigational Site — Guatemala City, Guatemala
• Pfizer Investigational Site — Budapest, Hungary
• Pfizer Investigational Site — Budapest, Hungary
• Pfizer Investigational Site — Szeged, Hungary
• Pfizer Investigational Site — Hyderabad, Andhra Pradesh, India
• Pfizer Investigational Site — Hyderabad, Andhra Pradesh, India
• Pfizer Investigational Site — Kochi, Kerala, India
• Pfizer Investigational Site — Bologna, Italy
• Pfizer Investigational Site — Tokyo, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.